Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 50 of 288 entries
View as:

Clinical Study to Evaluate the Food Effect of CKD-383 0.5/10/1000mg in Healthy Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT06695572 Org: User:
Start: 11/06/24 End: 12/13/24 Due: 12/13/25

Study to Evaluate the Drug Interaction Between CKD-519 and Rosuvastatin in Healthy Male Subjects

Phase: N/A Priority: Normal
NCT ID: NCT03175835 Org: User:
Start: 05/08/17 End: 06/19/17 Due: 06/19/18

A Clinical Study to Evaluate the Pharmacokinetics, Safety and Tolerability of CKD-355

Phase: N/A Priority: Normal
NCT ID: NCT03802162 Org: User:
Start: 02/15/19 End: 08/31/19 Due: 08/31/20

Clinical Study to Compare the Pharmacokinetic Characteristics and Safety Between CKD-357 and D578 in Healthy Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT03671941 Org: User:
Start: 05/25/18 End: 06/18/18 Due: 06/18/19

The Pharmacokinetics of D565 and the Drug Effect of D565 on Pharmacokinetic Characteristics of D930

Phase: N/A Priority: Normal
NCT ID: NCT03034486 Org: User:
Start: 02/17/17 End: 03/20/17 Due: 03/20/18

Clinical Trial to Evaluate the Efficacy and Safety of CKD-333 Tablet

Phase: N/A Priority: Normal
NCT ID: NCT03583905 Org: User:
Start: 04/04/18 End: 07/17/19 Due: 07/17/20

Phase I Clinical Trial for Comparison of Pharmacokinetic Characteristics of Vorico Injection 200mg(Voriconazole) and Vfend® IV 200mg for Single Dose Crossover Intravenous Infusion in Healthy Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT02631954 Org: User:
Start: 09/30/15 End: 11/30/15 Due: 11/30/16

Drug-drug Interaction Study(CKD-501, Amlodipine)

Phase: N/A Priority: Normal
NCT ID: NCT01341392 Org: User:
Start: 04/30/11 End: 08/31/11 Due: 08/31/12

A Clinical Study to Evaluate the Efficacy and Safety of CKD-351

Phase: N/A Priority: Normal
NCT ID: NCT04448223 Org: User:
Start: 06/11/20 End: 12/05/22 Due: 12/05/23

CKD-391 Pharmacokinetic Study

Phase: N/A Priority: Normal
NCT ID: NCT02461004 Org: User:
Start: 07/31/15 End: 10/31/15 Due: 10/31/16

Study to Compare the Safety and Pharmacokinetics of CKD-330 8/5mg With Coadministration of the Two Separate Drugs

Phase: N/A Priority: Normal
NCT ID: NCT02548286 Org: User:
Start: 08/31/15 End: 09/30/15 Due: 09/30/16

A Drug-drug Interaction Study to Investigate the Pharmacokinetic Interactions Between CKD-508, Midazolam, and Rosuvastatin in Healthy Adult Male Participants

Phase: N/A Priority: Normal
NCT ID: NCT06979973 Org: User:
Start: 05/14/25 End: 08/16/25 Due: 08/16/26

A Clinical Trial to Compare the Pharmacokinetics and Tolerability of CKD-348

Phase: N/A Priority: Normal
NCT ID: NCT04258865 Org: User:
Start: 03/25/20 End: 05/13/20 Due: 05/13/21

A Clinical Study to Evaluate the Pharmacokinetics and Safety of CKD-396

Phase: N/A Priority: Normal
NCT ID: NCT04246190 Org: User:
Start: 02/24/20 End: 07/16/20 Due: 07/16/21

CKD-506 Drug-Drug Interaction Study in Healthy Male Subjects

Phase: N/A Priority: Normal
NCT ID: NCT05238948 Org: User:
Start: 02/28/22 End: 04/29/22 Due: 04/29/23

A Phase 1/2a Study to Assess the Safety and Efficacy of CKD-516 Tab. in Combination With Irinotecan Inj.

Phase: N/A Priority: Normal
NCT ID: NCT03076957 Org: User:
Start: 12/31/16 End: 06/30/19 Due: 06/30/20

An Evaluation of Glycemic Control Effects of Mono Therapy CKD-501 in Patients With Type 2 Diabetes Mellitus

Phase: N/A Priority: Normal
NCT ID: NCT01001611 Org: User:
Start: 10/31/09 End: 01/31/12 Due: 01/31/13

MYREPTIC-N® or MY-REPT® in Stable Patients After Kidney Transplant Recipients

Phase: N/A Priority: Normal
NCT ID: NCT06044493 Org: User:
Start: 11/15/23 End: 11/30/25 Due: 11/30/26

CKD-504 in SAD and MAD in Healthy Korean and Caucasian Adult Male and Female Subjects

Phase: N/A Priority: Normal
NCT ID: NCT03713892 Org: User:
Start: 05/23/18 End: 12/31/20 Due: 12/31/21

Bioequivalence Study (Candesartan 16 mg and Amlodipine 5 mg) - A

Phase: N/A Priority: Normal
NCT ID: NCT02801526 Org: User:
Start: 04/30/15 End: 08/31/15 Due: 08/31/16

The Study to Evaluate Efficacy and Safety of Newrabell® Tab.(Rabeprazole Sodium) 10mg b.i.d in Refractory GERD

Phase: N/A Priority: Normal
NCT ID: NCT01860482 Org: User:
Start: 04/30/13 End: 05/31/15 Due: 05/31/16

CKD-828 Drug Interaction Study (S-amlodipine)

Phase: N/A Priority: Normal
NCT ID: NCT01356043 Org: User:
Start: 05/31/11 End: 08/31/11 Due: 08/31/12

Study to Evaluate the Pharmacokinetic Characteristics of Luckyvec 400mg Tablet, in Healthy Subjects

Phase: N/A Priority: Normal
NCT ID: NCT01270984 Org: User:
Start: 11/30/10 End: 12/31/10 Due: 12/31/11

Clinical Study to Investigate the Pharmacokinetic Profiles and Safety of CKD-333 in Healthy Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT04019743 Org: User:
Start: 07/28/19 End: 09/04/19 Due: 09/04/20

A Clinical Trial to Evaluate the Tolerability and Pharmacokinetics of CKD-386(3) 80/20/10mg

Phase: N/A Priority: Normal
NCT ID: NCT05245084 Org: User:
Start: 03/15/22 End: 06/20/22 Due: 06/20/23